Search Results - "Chard, Ryan A."
-
1
Increasing the Bioavailability of RuIII Anticancer Complexes through Hydrophobic Albumin Interactions
Published in Chemistry : a European journal (09-12-2013)“…A series of pyridine‐based derivatives of the clinically successful RuIII‐based complexes indazolium [trans‐RuCl4(1 H‐indazole)2] (KP1019) and sodium…”
Get full text
Journal Article -
2
Increasing the bioavailability of Ru(III) anticancer complexes through hydrophobic albumin interactions
Published in Chemistry : a European journal (09-12-2013)“…A series of pyridine-based derivatives of the clinically successful Ru(III)-based complexes indazolium [trans-RuCl4(1H-indazole)2] (KP1019) and sodium…”
Get full text
Journal Article -
3
Pyridine Analogues of the Antimetastatic Ru(III) Complex NAMI-A Targeting Non-Covalent Interactions with Albumin
Published in Inorganic chemistry (16-01-2012)“…A series of pyridine-based derivatives of the antimetastatic Ru(III) complex imidazolium [trans-RuCl4(1H-imidazole)(DMSO-S)] (NAMI-A) have been synthesized…”
Get full text
Journal Article -
4
Increasing the Bioavailability of Ru III Anticancer Complexes through Hydrophobic Albumin Interactions
Published in Chemistry : a European journal (09-12-2013)“…Abstract A series of pyridine‐based derivatives of the clinically successful Ru III ‐based complexes indazolium [ trans ‐RuCl 4 (1 H ‐indazole) 2 ] (KP1019)…”
Get full text
Journal Article -
5
Increasing the Bioavailability of Ru super(III) Anticancer Complexes through Hydrophobic Albumin Interactions
Published in Chemistry : a European journal (01-12-2013)“…A series of pyridine-based derivatives of the clinically successful Ru super(III)-based complexes indazolium [trans-RuCl sub(4)(1H-indazole) sub(2)] (KP1019)…”
Get full text
Journal Article